New Drug Application supported by results from the Phase 2b SunRISe-1 study RARITAN, N.J., JULY 17, 2025 – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug… Read More
GOTHENBURG, SWEDEN AND WARSAW, IND. – July 10, 2025 – Global MedTech companies Getinge and Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), today announced a strategic partnership where Zimmer… Read More
New class of Eureka Fellows selected for their outstanding efforts to build a healthier, more equitable world and will receive support to amplify their sustainability impact in Canada and around… Read More
Children with chronic medical conditions face a significantly higher risk of hospitalization due to respiratory syncytial virus (RSV) in their first two respiratory virus seasons, according to a recent study… Read More
This Insight Brief delves into the rapidly evolving landscape of clinical research for cell and gene therapies (CAGT) in autoimmune diseases. As the industry’s focus expands beyond oncology, the autoimmune space… Read More
